NCT03868943 Solriamfetol in Improving Sleep in Patients With Grade II-IV Glioma Status TERMINATED Phase PHASE2
NCT03865355 Blood and Cerebrospinal Fluid Metabolomic Profile in Glioma Patients Status COMPLETED Phase N/A
NCT03843814 Pilot Study Using Amide Proton Transfer Magnetic Resonance Imaging Distinguishing Glioma Status TERMINATED Phase NA
NCT03796273 Ketoconazole Before Surgery in Treating Patients With Recurrent Glioma or Breast Cancer Brain Metastases Status TERMINATED Phase EARLY_PHASE1
NCT03739411 Hyperpolarized Imaging in Diagnosing Participants With Glioma Status RECRUITING Phase PHASE1
NCT03739372 Clinical Benefit of Using Molecular Profiling to Determine an Individualized Treatment Plan for Patients With High Grade Glioma Status ACTIVE_NOT_RECRUITING Phase NA
NCT03722355 Hyperfractionated RT With BCNU Versus Conventional RT With BCNU for Supratentorial Malignant Glioma Status COMPLETED Phase PHASE3
NCT03718767 Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03706625 Integrated Discovery of New Immuno-Molecular Actionable Biomarkers for Tumors With Immune-suppressed Environment Status COMPLETED Phase N/A
NCT03690570 Long Term Follow up of Patients Under 5 Years of Age With High Grade Glioma Diagnosed in France Between 1990 and 2015 Status UNKNOWN Phase N/A
NCT03687957 rhIL-7-hyFc on Increasing Lymphocyte Counts in Patients With Newly Diagnosed Non-severe Lymphopenic Gliomas Following Radiation and Temozolomide Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT03684109 Non-invasive Glioma Characterization Through Molecular Imaging Status RECRUITING Phase NA
NCT03641391 Awake Intraoperative Language Mapping and Chinese Probabilistic Map Construction Status UNKNOWN Phase NA
NCT03638206 Autologous CAR-T/TCR-T Cell Immunotherapy for Malignancies Status UNKNOWN Phase PHASE1/PHASE2
NCT03638167 EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors Status COMPLETED Phase PHASE1
NCT03632317 A Study of Panobinostat in Combination With Everolimus for Children and Young Adults With Gliomas Status WITHDRAWN Phase PHASE2
NCT03626896 Safety of BBB Disruption Using NaviFUS System in Recurrent Glioblastoma Multiforme (GBM) Patients Status COMPLETED Phase NA